The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ASPEN: Long-term follow-up results of a phase 3 randomized trial of zanubrutinib (ZANU) versus ibrutinib (IBR) in patients with Waldenström macroglobulinemia (WM).
 
Constantine Si Lun Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Loxo/Lilly; Novartis; Pharmacyclics; Roche/Genentech
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); BeiGene (Inst); Janssen-Cilag (Inst)
 
Ramón Garcia-Sanz
Honoraria - Amgen; Astellas Pharma; Beigene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Janssen
Research Funding - Astellas Pharma; Gilead Sciences (Inst); Incyte (Inst)
Patents, Royalties, Other Intellectual Property - BIOMED 2 primers (Inst)
Travel, Accommodations, Expenses - Janssen; Takeda (I)
Other Relationship - Spanish Society of Hematology
 
Stephen Opat
Honoraria - Abbvie; AstraZeneca; CSL Behring; Gilead Sciences; Janssen; Merck; Mundipharma; Roche; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; CSL Behring; Gilead Sciences; Janssen; Merck; Mundipharma; Novartis; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Celgene (Inst); Epizyme (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche
 
Shirley D'Sa
Honoraria - BeiGene; Janssen; Sanofi
Consulting or Advisory Role - BeiGene; Janssen; Sanofi
Speakers' Bureau - Janssen
Research Funding - Janssen
Expert Testimony - Janssen
Travel, Accommodations, Expenses - BeiGene; Janssen
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; Debiopharm Group; Epizyme; Janssen-Cilag; Roche
Research Funding - Acerta Pharma; Bayer; BeiGene; Debiopharm Group; Epizyme; Incyte; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
 
Hui-Peng Lee
No Relationships to Disclose
 
Gavin Cull
Research Funding - BeiGene
 
Roger G. Owen
Honoraria - AstraZeneca; BeiGene; Janssen-Cilag
Consulting or Advisory Role - BeiGene; Janssen-Cilag
 
Paula Marlton
Honoraria - Abbvie; Roche
Consulting or Advisory Role - Abbvie; Astellas Pharma; BeiGene; Gilead Sciences; Janssen-Cilag; Jazz Pharmaceuticals; Novartis; Pfizer; Roche
 
Bjorn E. Wahlin
Research Funding - Incyte; Roche
 
Alessandra Tedeschi
Consulting or Advisory Role - Abbvie; AstraZeneca; Beigene; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Beigene; Janssen
 
Jorge J. Castillo
Consulting or Advisory Role - Abbvie/Pharmacyclics; Beigene; Janssen; Polyneuron Pharmaceuticals; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Janssen (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Tanya Siddiqi
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Celgene; Juno Therapeutics; Pharmacyclics
Speakers' Bureau - AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Pharmacyclics/Janssen
Research Funding - Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Sanofi (Inst); Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Christian Buske
Honoraria - Abbvie; Beigene; Celltrion; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Pfizer; Regeneron; Roche/Genentech
Consulting or Advisory Role - Abbvie; Beigene; Celltrion; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Pfizer; Regeneron; Roche
Speakers' Bureau - Abbvie; BeiGene; Celltrion; Gilead Sciences; Janssen; Pfizer; Roche
Research Funding - Amgen; Celltrion; Janssen; MSD; Pfizer; Roche/Genentech
 
Veronique Leblond
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Janssen Oncology; Lilly; MSD Oncology; Roche Pharma AG
Consulting or Advisory Role - Abbvie; AstraZeneca; beigene; janssen; Lilly
Speakers' Bureau - Abbvie; AstraZeneca; BeiGene
Travel, Accommodations, Expenses - Abbvie
 
Wai Y. Chan
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene; Bristol-Myers Squibb
 
Jingjing Schneider
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Aileen Cohen
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jane Huang
Employment - BeiGene
Leadership - BeiGene; Protara Therapeutics
Stock and Other Ownership Interests - BeiGene; Roche
Research Funding - BeiGene
Patents, Royalties, Other Intellectual Property - BeiGene
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda